Scientists Question Data Behind an Experimental Alzheimer’s Drug
The New York Times
Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.
More Related News
Set News Language for United States
Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available
Set News Language for World
Primary Language (Mandatory)
Other Language(s) (Optional)
Set News Source for United States
Primary Source (Mandatory)
Other Source[s] (Optional)
Set News Source for World
Primary Source (Mandatory)
Other Source(s) (Optional)